Sánchez-Briales, P.; Marques Vidas, M.; López-Sánchez, P.; López-Illázquez, M.V.; MartÃn-Testillano, L.; Vedat-Ali, A.; Portolés, J.
The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. J. Clin. Med. 2024, 13, 1360.
https://doi.org/10.3390/jcm13051360
AMA Style
Sánchez-Briales P, Marques Vidas M, López-Sánchez P, López-Illázquez MV, MartÃn-Testillano L, Vedat-Ali A, Portolés J.
The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine. 2024; 13(5):1360.
https://doi.org/10.3390/jcm13051360
Chicago/Turabian Style
Sánchez-Briales, Paula, MarÃa Marques Vidas, Paula López-Sánchez, MarÃa Victoria López-Illázquez, LucÃa MartÃn-Testillano, Aylin Vedat-Ali, and Jose Portolés.
2024. "The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus" Journal of Clinical Medicine 13, no. 5: 1360.
https://doi.org/10.3390/jcm13051360
APA Style
Sánchez-Briales, P., Marques Vidas, M., López-Sánchez, P., López-Illázquez, M. V., MartÃn-Testillano, L., Vedat-Ali, A., & Portolés, J.
(2024). The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine, 13(5), 1360.
https://doi.org/10.3390/jcm13051360
